Form 4: Zimmer Biomet Executive Mark Bezjak Reports Stock Transactions

Mark Bezjak, President, Americas at Zimmer Biomet, reports the vesting of restricted stock units and subsequent share withholding for tax obligations.

Summary

• On February 20, 2025, Mark Bezjak, President, Americas at Zimmer Biomet Holdings, Inc., reported transactions involving the company's common stock.
• Bezjak vested 2,519 restricted stock units (RSUs), each representing a contingent right to receive one share of Zimmer Biomet common stock.
• Simultaneously, 694 shares were withheld by the company to satisfy tax withholding obligations related to the vesting of the RSUs at a price of $103.46.
• Following these transactions, Bezjak directly owns 12,151 shares of Zimmer Biomet common stock and 5,037 restricted stock units.
• One-third of the RSUs vested on February 20, 2025, with the remaining RSUs vesting in two equal installments on February 20, 2026, and February 20, 2027.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions, with no inherent positive or negative implications for the company's performance.

Future Outlook

The remaining RSUs will vest in two installments on February 20, 2026, and February 20, 2027.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, common in publicly traded companies to ensure transparency and compliance with SEC regulations.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it involves the vesting of previously granted equity compensation.

Key Dates